Open AccessUSE OF OXYGENATED PERFLUOROCARBON TOWARD MAKING EVERY PANCREAS COUNT
Author(s) -
Christopher A. Fraker,
Rodolfo Alejandro,
Camillo Ricordi
Publication year - 2002
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200212270-00032
Subject(s) - islet , transplantation , pancreas transplantation , medicine , islet cell transplantation , diabetes mellitus , intensive care medicine , miami , type 1 diabetes , pancreas , endocrinology , kidney transplantation , environmental science , soil science
The past few years have seen significant advancement in the clinical relevance of intraportal islet cell transplantation for treatment of type 1 diabetes mellitus. The implementation of novel protocols, such as the one developed by the group of Shapiro and collaborators in Edmonton, has revitalized the enthusiasm for cellular transplantation as a treatment for diabetes by improving the success rates and long-term function of islet grafts. Improved results in clinical islet transplantation reported by the groups in Edmonton, Miami, and Minneapolis have re-proposed the much simpler outpatient cell transplant procedure as an alternative to the more risky and technically challenging whole-organ pancreas transplantation.